Literature DB >> 32026572

Incidence of retinal artery occlusion in Germany.

Julia Pick1, Stefan Nickels2, Frauke Saalmann1, Robert P Finger3, Alexander K Schuster2.   

Abstract

Entities:  

Year:  2020        PMID： 32026572     DOI： 10.1111/aos.14369

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  4 in total

Review 1.  Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis.

Authors:  Lele Huang; Yujie Wang; Ruijun Zhang
Journal:  J Neurol       Date:  2021-10-09       Impact factor: 4.849

2.  Retinal Vascular Occlusion after COVID-19 Vaccination: More Coincidence than Causal Relationship? Data from a Retrospective Multicentre Study.

Authors:  Nicolas Feltgen; Thomas Ach; Focke Ziemssen; Carolin Sophie Quante; Oliver Gross; Alaa Din Abdin; Sabine Aisenbrey; Martin C Bartram; Marcus Blum; Claudia Brockmann; Stefan Dithmar; Wilko Friedrichs; Rainer Guthoff; Lars-Olof Hattenbach; Klaus R Herrlinger; Susanne Kaskel-Paul; Ramin Khoramnia; Julian E Klaas; Tim U Krohne; Albrecht Lommatzsch; Sabine Lueken; Mathias Maier; Lina Nassri; Thien A Nguyen-Dang; Viola Radeck; Saskia Rau; Johann Roider; Dirk Sandner; Laura Schmalenberger; Irene Schmidtmann; Florian Schubert; Helena Siegel; Martin S Spitzer; Andreas Stahl; Julia V Stingl; Felix Treumer; Arne Viestenz; Joachim Wachtlin; Armin Wolf; Julian Zimmermann; Marc Schargus; Alexander K Schuster
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

3.  Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!

Authors:  Oana M Dumitrascu; Nancy J Newman; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2020-09       Impact factor: 4.415

4.  Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) are more prominent in retinal artery occlusion (RAO) compared to retinal vein occlusion (RVO).

Authors:  Guanghao Qin; Fang He; Hongda Zhang; Emmanuel Eric Pazo; Guangzheng Dai; Qingchi Yao; Wei He; Ling Xu; Tiezhu Lin
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.